Contact us
![]() |
[email protected] |
![]() |
3275638434 |
![]() |
![]() |
Paper Publishing WeChat |
Useful Links
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Article
Author(s)
Fábio Eduardo de Campos1, Efrain Araujo Perini1, Carlos Leonel Zapparoli Júnior1, Wilson Aparecido Parejo Calvo1 and Valeriia Niowaveinc Starovoitova2
Full-Text PDF
XML 834 Views
DOI:10.17265/2162-5298/2018.03.004
Affiliation(s)
1. Nuclear and Energy Research Institute (IPEN), the University of São Paulo, São Paulo, SP 05508-000, Brazil
2. NiowaveInc, 1012 N Walnut St, Lansing, MI48906, USA
ABSTRACT
The worldwide GMP
(Good Manufacturing Practices) guidelines issued for injectable pharmaceuticals
globally agree that the vials filling operation must be performed under air
cleanliness Grade A. The air cleanliness classifications adopted by the WHO
(World Health Organization) define the particle diameter size, the sampling
occupancy state and the limit concentration of viable particles. To reach
conformity regarding the microbial limits foreseen at the GMP guidelines, a
microbiological monitoring program must be stablished for selected sampling
points such as active air sampling, passive air sampling (settle plate method),
surfaces sampling (contact method), personnel sampling (gloves and clothes),
compressed gas, materials and equipment that may interfere and compromise the
product microbiological quality. The key elements for a GMP certification are
directly related to a qualification and validation program for
radiopharmaceutical manufacturers that must be clearly defined and documented
by a validation master plan, foreseen by the manufactures Quality Assurance
office. This study describes each qualification step and test for DQ (Design
Qualification), IQ (Installation Qualification), OQ (Operation Qualification)
and PQ (Performance Qualification) that must be carried out and carefully
planned when it comes to hot cells and isolator systems in accordance with the
GMP requirements foreseen by international regulatory and supervisory bodies.
KEYWORDS
Injectable radiopharmaceuticals, GMP, qualifications, regulations.
Cite this paper
References